Acrylic Acid

Acrylic Acid

SCHEMBL265149

C=C(C)C(=O)OCC.C=CC(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.52
TSHR P16473 4/20 0.46
GLO1 Q04760 1/20 0.45
ALDH1A1 P00352 7/20 0.44
HCAR2 Q8TDS4 1/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 2/20 0.41
CYP2D6 P10635 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
EGLN1 Q9GZT9 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL27651708 1.00 THRB (0.52) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid SCHEMBL23825514 0.98 THRB (0.50) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid SCHEMBL28326460 0.98 THRB (0.50) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid SCHEMBL17746674 0.96 THRB (0.48) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid SCHEMBL17746665 0.96 THRB (0.48) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid SCHEMBL27354650 0.94 THRB (0.47) THRBTSHRGLO1ALDH1A1HCAR2
Acrylic Acid Ethyl Ester SCHEMBL20573127 0.93 THRB (0.46) THRBTSHRGLO1ALDH1A1HCAR2
SCHEMBL4713738 0.89 THRB (0.53) THRBTSHRGLO1ALDH1A1LMNA
Acrylic Acid SCHEMBL5959113 0.88 TSHR (0.68) THRBTSHRGLO1ALDH1A1HCAR2
Maleic Acid SCHEMBL15653018 0.88 HCAR2 (0.57) THRBTSHRGLO1ALDH1A1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135608-A1 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER CURACLE CO., LTD. (KR) 2023-05-04 US claimed
EP-3977986-A1 ENTERIC TABLET CONTAINING DIMETHYL FUMARATE CURACLE Co., Ltd. (KR) 2022-04-06 EP claimed
US-20220087942-A1 ENTERIC TABLET CONTAINING DIMETHYL FUMARATE CURACLE CO., LTD. (KR) 2022-03-24 US claimed
CN-111511365-A Improved pharmaceutical formulations 分散技术有限责任公司 2020-08-07 CN claimed
US-8557491-B2 Toner, developer, toner container, process cartridge, and image forming method RICOH COMPANY, LTD. (JP) 2013-10-15 US claimed
EP-0409657-A2 Impact modified thermoplastic blends NOVACOR CHEMICALS (CANADA) LTD. (CA) 1991-01-23 EP claimed
EP-4658374-A1 METHODS FOR PREPARING CRYSTALLINE PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Janssen Pharmaceutica NV (BE) 2025-12-10 EP disclosed
EP-4472999-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND PHARMACEUTICAL COMPOSITIONS THEREOF Janssen Pharmaceutica NV (BE) 2024-12-11 EP disclosed
CN-118829647-A Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof 詹森药业有限公司 2024-10-22 CN disclosed
CN-118634202-A Room temperature stable oral calcitonin formulations 帕克治疗公司 2024-09-13 CN disclosed
WO-2024163643-A1 METHODS FOR PREPARING CRYSTALLINE PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2024-08-08 WO disclosed
US-20240210847-A1 TONER, DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2024-06-27 US disclosed
CN-110267675-B Room temperature stable oral calcitonin formulations 帕克治疗公司 2024-06-18 CN disclosed
EP-0438746-A1 Developer for electrostatic electrophotography SONY CORPORATION (JP) 1991-07-31 EP disclosed
EP-0433012-A2 Developer cartridges SONY CORPORATION (JP) 1991-06-19 EP disclosed
EP-0348844-A2 Electrophotographic process SONY CORPORATION (JP) 1990-01-03 EP disclosed
EP-0333415-A2 An electrophotographic lithographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 1989-09-20 EP disclosed
US-4765982-A INSECTICIDE ADHERED TO ROUGH FIBERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-08-23 US disclosed
US-4683132-A Compositions, devices, and methods for extended control of insect activity MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-07-28 US disclosed
US-3930862-A DYE DEVELOPER TRANSFER PHOTOSENSITIVE MATERIAL WITH SUBSTITUTED CATECHOL AUXILIARY DEVELOPER FUJI PHOTO FILM CO., LTD. (JA) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220087942-A1 ENTERIC TABLET CONTAINING DIMETHYL FUMARATE SI, FH, SLC10A2 THRB 4489/4885TSHR 4434/4885GLO1 350/4885
US-20230135608-A1 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER SLC5A2, FH, SLC5A1 THRB 4719/4885TSHR 4784/4885GLO1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.